• / Free eNewsletters & Magazine
  • / My Account
Home>Stocks>Imclone Systems

Imclone Systems

  1. Verastem Expands Duvelisib Development Program to Include Peripheral T-Cell Lymphoma

    Verastem Expands Duvelisib Development Program to Include Peripheral T-Cell Lymphoma

1

©2017 Morningstar Advisor. All right reserved.